Data completeness
0/8 — Limited
Drug data last refreshed 53m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
This is a fixed-dose combination tablet containing three nucleoside reverse transcriptase inhibitors (NRTIs): lamivudine, nevirapine, and zidovudine, used to treat HIV-1 infection. The combination works by inhibiting reverse transcriptase enzyme activity, preventing viral replication in infected cells. This pre-launch oral suspension/tablet formulation from Cipla targets treatment-naive and experienced HIV patients requiring multi-drug antiretroviral therapy.
Pre-Launch
Pre-launch stage indicates small core team with focus on regulatory completion, manufacturing scale-up, and market entry preparation; team expansion expected post-approval.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This pre-launch product offers entry and mid-career opportunities in regulatory completion, market entry strategy, and launch execution for professionals focused on global HIV therapy markets. Career growth will depend on successful FDA/international approvals and post-launch commercial performance in emerging markets where cost-effective triple-therapy combinations remain clinically relevant.
Regulatory Affairs Manager
Worked on LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE at Cipla? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.